SCHEMBL7303711

SCHEMBL7303711

COc1cccc([S+]([O-])C(CC(=O)NO)Cc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 7/20 0.51
MMP1 P03956 6/20 0.51
MMP3 P08254 6/20 0.51
PDE4A P27815 5/20 0.51
PDE4B Q07343 5/20 0.51
PDE4C Q08493 5/20 0.51
PDE4D Q08499 5/20 0.51
USP2 O75604 1/20 0.46
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
MMP9 P14780 2/20 0.45
MMP8 P22894 1/20 0.45
RAB9A P51151 2/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
MEP1B Q16820 1/20 0.43
MMP13 P45452 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303121 0.87 MMP2 (0.60) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7308918 0.81 FCER2 (0.48) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7308706 0.81 MMP1 (0.46) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7303135 0.77 MME (0.47) MMP2MMP1MMP9MMP8MMP13
SCHEMBL7309199 0.75 NFE2L2 (0.44) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7309205 0.75 MMP2 (0.51) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7299652 0.74 MME (0.44) MMP1
SCHEMBL8203704 0.74 MMP3 (0.63) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL7312804 0.73 MMP1 (0.50) MMP2MMP1MMP3PDE4APDE4B
SCHEMBL27477945 0.72 PPARG (0.47) MMP2MMP9MMP8HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed